AEM vs GGB

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

GGB presents a dichotomy between a strong balance sheet and poor operational performance. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the current price of $4.32 sits slightly above the Graham Number ($4.14) and significantly above the growth-based intrinsic value ($0.98). While the company maintains low leverage and high liquidity, consistent earnings misses (0/4 in the last year) and thin profit margins suggest fundamental weakness despite recent price momentum.